Profile picture

Professor Stephan Jacob

Villingen (Germany)
Follow
Logo ESC

Contributor content

Case presentations on pharmacologic treatment
Presentation
Case presentations on pharmacologic treatment
See more
Q&A and panel discussion.
Presentation
Q&A and panel discussion.
See more
Practical considerations for the use of GLP-1 RAs in the clinic.
Presentation
Practical considerations for the use of GLP-1 RAs in the clinic.
See more
What should we do when we are presented with an individual who has CVD and comorbid obesity?
Presentation
What should we do when we are presented with an individual who has CVD and comorbid obesity?
See more
Type 2 Diabetes & CV outcomes: more than Glucose management? Lessons from GLP1-ra trials.
Presentation
Type 2 Diabetes & CV outcomes: more than Glucose management? Lessons from GLP1-ra trials.
See more
Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice
Presentation
Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice
See more
Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.
Presentation
Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.
See more
Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.
Presentation
Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.
See more
Changing focus in diabetes: From glucose to cardiovascular risk management.
Presentation
Changing focus in diabetes: From glucose to cardiovascular risk management.
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources